Redeye: ADDvise Q3 2023 - The profitable growth story continues
Redeye updates its estimates and valuation following ADDvise releasing its Q3 2023 report. The company’s third-quarter numbers came in above our projections, fuelled by stronger-than-expected Lab sales. We expect continued M&A-led and organic growth. We make moderate changes to our estimates and valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/